SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Procter&Gamble Healt - Quaterly Results

29 May 2025 Evaluate
The company witnessed a 23.17% growth in the revenue at Rs. 3109.90 millions for the quarter ended March 2025 as compared to Rs. 2524.80 millions during the year-ago period.Net Profit recorded in the quarter ended March 2025 rise to 31.40% to Rs. 611.80  millions  compared to R. 465.60 millions in corresponding previous quarter.The company reported a good operating profit of 840.30 millions compared to 697.10 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202406 202306 % Var
Sales 3109.90 2524.80 23.17 9341.70 8673.80 7.70 11512.60 12296.20 -6.37
Other Income 31.10 22.70 37.00 103.50 135.00 -23.33 156.30 183.90 -15.01
PBIDT 840.30 697.10 20.54 3287.40 2712.50 21.19 3216.30 3430.70 -6.25
Interest 1.30 1.50 -13.33 4.30 5.20 -17.31 7.20 7.70 -6.49
PBDT 839.00 695.60 20.62 3283.10 2707.30 21.27 3007.20 3423.00 -12.15
Depreciation 53.70 68.40 -21.49 166.90 202.40 -17.54 274.00 281.00 -2.49
PBT 785.30 627.20 25.21 3116.20 2504.90 24.40 2733.20 3142.00 -13.01
TAX 173.50 161.60 7.36 772.10 662.90 16.47 723.40 847.30 -14.62
Deferred Tax -33.60 -1.40 2300.00 -4.90 -18.60 -73.66 -86.00 -50.60 69.96
PAT 611.80 465.60 31.40 2344.10 1842.00 27.26 2009.80 2294.70 -12.42
Equity 166.00 166.00 0.00 166.00 166.00 0.00 166.00 166.00 0.00
PBIDTM(%) 27.02 27.61 -2.14 35.19 31.27 12.53 27.94 27.90 0.13

Procter&Gamble Healt Share Price

5351.35 37.10 (0.70%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×